A Calgary-based biotech company is turning heads on Tuesday after it was announced that a recent study showed its lead drug candidate MB-204 demonstrated a 400% increase in the...

To read the full story on AllPennyStocks.com, click here.

Marvel Biosciences (TSXV:MRVL)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Marvel Biosciences
Marvel Biosciences (TSXV:MRVL)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Marvel Biosciences